|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income from operations | |||||
| Adjustments to reconcile net income to net cash provided (used) by operating activities: | |||||
| Acquired in-process research and development | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Net gain on disposal of assets | |||||
| Noncash lease expense | |||||
| Amortization of land use rights | |||||
| Deferred income taxes, net | |||||
| Bad debt expense and other non-cash items | |||||
| Accrued interest on bank deposit | |||||
| Accrued interest on long-term certificates of deposit | |||||
| Change in fair value of receivables from GCBP | |||||
| Change in fair value of derivative liabilities | |||||
| Change in fair value of warrant liability | |||||
| Equity loss of unconsolidated affiliates | |||||
| Divestiture losses | |||||
| Loss on disposal of property and equipment | |||||
| Changes in operating assets and liabilities: | |||||
| Notes receivable | |||||
| Accounts receivable | |||||
| Accounts and note receivables | |||||
| Other receivables from GNI | |||||
| Inventories | |||||
| Prepaid and other assets | |||||
| Income tax payable | |||||
| Accounts payable | |||||
| Other noncurrent liabilities | |||||
| Due to related parties | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net proceeds from CVR liability settlement | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Acquisition of intangible assets | |||||
| Purchase of certificates of deposit | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of equipment | |||||
| Purchase of equity method investment | |||||
| Cash and cash equivalents acquired in connection with the GNI USA Contributions | |||||
| Payments made for acquisition costs | |||||
| Cash balance in a disposed subsidiary | |||||
| Maturity of certificates of deposit | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Offering costs paid | |||||
| Deferred offering costs | |||||
| Proceeds from the issuance of common stock | |||||
| 2024 ATM Program | |||||
| Public Offering | |||||
| Total proceeds from the issuance of common stock | |||||
| Proceeds from the exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Disclosure of Non-Cash Financing and Investing Activities: | |||||
| Deemed issuance of common stock and Convertible Preferred Stock to former stockholders of Catalyst upon the GNI USA Contributions | |||||
| Advance payment for Convertible Preferred Stock and Preferred Stock Warrants acquired upon the GNI USA Contributions | |||||
| Disposal consideration in other receivables from GNI | |||||
| Acquisition costs in due to related parties | |||||
| Right-of-use asset obtained in exchange for operating lease liabilities | |||||
| Proceeds from the exercise of stock options included in other receivable | |||||
| Convertible preferred stock conversion | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash paid for income taxes | |||||
Loading...